EPHX2 and atherosclerosis: Previous studies demonstrated that sEH inhibition greatly reduced the increasement of cytokines, chemokines and adhesion molecules, impaired mitochondrial dysfunction, and thus suppressed the development of atherosclerosis and hypertension [13].